Table 6: Comparison of our data to historical clinical trials.

Mortality at 30 daysAmputation rateSuccess of revascularization

Rochester trial16%18%70%
STILE trial4%5%82%
TOPAS trial5%2%80%
Our study40.7%2%90.5% (68.7% + 21.8%)

thrombectomy as first-line treatment combined with overnight fibrinolysis.